John Matthew Collins - 31 Jan 2025 Form 4 Insider Report for CALIX, INC (CALX)

Reporting relationship: Chief Commercial Ops Officer
Issuer ticker: CALX
Reported as of: 31 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Feb 2025, 16:12:11 UTC
Prior SEC filing: 12 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Tom Gemetti as Attorney-in-Fact for John Matthew Collins

Key filing fact

John Matthew Collins filed Form 4 for CALIX, INC (CALX) on 04 Feb 2025.

Key facts

This page summarizes John Matthew Collins's Form 4 filing for CALIX, INC (CALX).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 04 Feb 2025, 16:12.

Change

Previous filing in this sequence was filed on 12 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

(CALX) transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +107,775
Change %
Price: $0.000000
Shares after: 107,775
Date: 31 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 107,775
Exercise price: $34.26
Footnotes: F1

(CALX) transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +68,850
Change %
Price: $0.000000
Shares after: 68,850
Date: 31 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 68,850
Exercise price: $34.26
Footnotes: F2

(CALX) transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +195,000
Change %
Price: $0.000000
Shares after: 195,000
Date: 31 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 195,000
Exercise price: $39.68
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 225,000 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 107,775 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

Footnote F2

On February 8, 2024, the reporting person was granted a performance-based option to purchase 75,000 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 68,850 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

Footnote F3

The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.